Go Back
REPLIGEN CORP reports $28.8 million Q1 profit
By USInMinutes - May 02, 2023, 02:34 PM ET
Last Updated - Jul 18, 2023, 03:44 PM EDT
The company generated $182.70 million in quarterly revenue
REPLIGEN CORP [RGEN] has reported fiscal Q1 profit of $28.80 million.
On a per-share basis, the DE based company said its diluted earnings are $0.51.
The Biological Products, Except Diagnostic Substances firm posted revenue of $182.70 million in this period.
Also Read:
- Repligen Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance
- Repligen to Report First Quarter 2023 Financial Results
- Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
- Repligen Reports Fourth Quarter and Full Year 2022 Financial Results
- Repligen to Report Fourth Quarter and Full Year 2022 Financial Results
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News